Skip to main content

Table 8 Final model for OC recurrence (A) and survival (B) for CA-125 changes 6 months after the treatment

From: Rising serum CA-125 levels within the normal range is strongly associated recurrence risk and survival of ovarian cancer

Variable

Recurrence

Survival

HR

95%CI

P

HR

95%CI

P

CA-125 change < 0 U/ml

1.00

-

-

1.00

-

-

CA-125 change 0-5 U/ml

3.68

1.45-9.30

0.0060

1.68

0.35-8.10

0.5199

CA-125 change > 5 U/ml

19.00

6.48-55.76

0.0001

5.26

1.12-24.85

0.0360

Clear cell histology

36.15

7.40-176.66

0.0001

16.62

1.21-228.85

0.0356

FIGO stage (I&II vs III&IV)

0.14

0.05-0.41

0.0003

-

-

-